Ondine Biomedical Inc (OBI) — Working Capital to Net Assets Ratio
Ondine Biomedical Inc (OBI) has a Working Capital to Net Assets ratio of 70.8% as of December 2025. Working capital of GBX2.47 Million (current assets of GBX13.28 Million minus current liabilities of GBX10.81 Million) is measured against net assets of GBX3.49 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See OBI free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Ondine Biomedical Inc Working Capital to Net Assets (2001–2025)
This chart shows how Ondine Biomedical Inc's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2001 to 2025. As of December 2025, the ratio stands at 70.8%, reflecting working capital of GBX2.47 Million against net assets of GBX3.49 Million GBX. See Ondine Biomedical Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Ondine Biomedical Inc (2001–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Ondine Biomedical Inc from 2001 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Ondine Biomedical Inc (OBI) market capitalisation.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 70.8% | GBX2.47 Million | GBX3.49 Million | GBX13.28 Million | GBX10.81 Million | ▼ -20.0 pp |
| 2024 | 90.8% | GBX6.24 Million | GBX6.88 Million | GBX12.19 Million | GBX5.95 Million | ▲ +30.3 pp |
| 2023 | 60.4% | GBX1.26 Million | GBX2.08 Million | GBX4.75 Million | GBX3.49 Million | ▼ -35.9 pp |
| 2022 | 96.4% | GBX11.22 Million | GBX11.64 Million | GBX15.13 Million | GBX3.91 Million | ▼ -3.4 pp |
| 2021 | 99.7% | GBX29.58 Million | GBX29.66 Million | GBX33.50 Million | GBX3.92 Million | ▼ -0.9 pp |
| 2020 | 100.6% | GBX-34.04 Million | GBX-33.83 Million | GBX1.75 Million | GBX35.78 Million | ▼ -5.5 pp |
| 2019 | 106.1% | GBX-27.66 Million | GBX-26.07 Million | GBX1.01 Million | GBX28.67 Million | ▼ -6.2 pp |
| 2018 | 112.3% | GBX-20.11 Million | GBX-17.90 Million | GBX2.29 Million | GBX22.40 Million | ▼ -30.2 pp |
| 2017 | 142.5% | GBX-9.33 Million | GBX-6.55 Million | GBX2.82 Million | GBX12.15 Million | ▲ +309.3 pp |
| 2010 | -166.8% | GBX-465.70K | GBX279.19K | GBX1.64 Million | GBX2.11 Million | ▼ -188.7 pp |
| 2009 | 21.9% | GBX279.44K | GBX1.28 Million | GBX1.56 Million | GBX1.28 Million | ▼ -19.6 pp |
| 2008 | 41.5% | GBX554.68K | GBX1.34 Million | GBX2.05 Million | GBX1.50 Million | ▼ -49.7 pp |
| 2007 | 91.1% | GBX9.88 Million | GBX10.84 Million | GBX11.90 Million | GBX2.01 Million | ▼ -3.7 pp |
| 2006 | 94.9% | GBX15.74 Million | GBX16.59 Million | GBX17.58 Million | GBX1.84 Million | ▼ -2.0 pp |
| 2005 | 96.9% | GBX15.99 Million | GBX16.50 Million | GBX16.69 Million | GBX702.68K | ▲ +7401.3 pp |
| 2003 | -7304.5% | GBX16.63 Million | GBX-227.62K | GBX16.86 Million | GBX233.99K | ▼ -7404.5 pp |
| 2002 | 100.0% | GBX-143.28K | GBX-143.28K | GBX845.00 | GBX144.13K | ▲ +103.6 pp |
| 2001 | -3.6% | GBX-50.17K | GBX1.39 Million | GBX7.84K | GBX58.02K | — |